A randomised trial of evaluating a systematic intensive therapy using Continuous Glucose Monitoring (CGM) and Flash Glucose Monitoring (FGM) in clinical diabetes care
This study is a randomised, non-blinded, multi-centre, clinical study for persons with type 1 diabetes and HbA1c ≥ 58mmol/mol and treated with CGM or FGM. The main aim is to analyse if intensive systematic treatment via internet and telephone during 4 months improved HbA1c for persons with type 1 diabetes which are already treated with CGM or FGM, and if the effect continuous for 1-2 years after the intervention stops.
News from 2021:
This project had ongoing recruitment in 2021/2022.